Emfit
Emfit Ltd is a Finland-based manufacturer founded in 1990 that builds contact-free, under-mattress ballistocardiography sensors for sleep tracking, HRV/recovery, seizure detection, and senior care monitoring, selling via subscription, enterprise sales, APIs, and regional distributors.
- Company typePrivate
- Founded1990
- HeadquartersVaajakoski, Finland
- Headcount11–50
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Emfit does
Emfit Ltd is a Finland-based, founder-owned manufacturer founded in 1990 that builds contact-free vital signs and movement sensors using proprietary ferro-electret ballistocardiography (BCG) technology. Its sensors are placed under a mattress and detect heart rate, breathing rate, HRV, body movement, and seizure activity without requiring any wearable device, with cloud-based processing handling data analytics and remote transmission via WiFi or LTE-M. The company operates three core product lines: EMFIT QS for personal sleep and recovery tracking, EMFIT MM for nocturnal tonic-clonic seizure detection, and EMFIT CARE for senior care facilities needing fall prevention, wandering detection, and bed-occupancy monitoring. EMFIT QS is also offered as a Cloud API for research and OEM integration.
Emfit serves a horizontally diversified customer base spanning professional athletes, health-conscious consumers, senior care facilities, research institutions, and epilepsy patients, with distribution in over 60 countries. Revenue is generated through a mix of subscription-based pricing (introduced in March 2024 for EMFIT QS at 180/100/50 EUR in years 1/2/3+), monthly B2B subscriptions for EMFIT CARE, hardware sales through distribution partners (Epi USA for North America, Abilia internationally), and API/licensing agreements for research customers. The company holds CE, FCC, GDPR, and CCPA compliance certifications and reports over 100 clinical and scientific publications validating its technology.
The company is privately held, bootstrapped, and led by CEO and co-founder Heikki Räisänen. It employs approximately 20 people across its Vaajakoski, Finland headquarters and a San Marcos, Texas distribution entity, with no disclosed external funding rounds. Its go-to-market combines product-led DTC e-commerce, sales-led enterprise quoting, API-first research engagement, and regional channel partners for the seizure monitor line.
Emfit firmographics
Firmographics- Name
- Emfit
- Legal name
- Emfit Ltd
- Website
- https://emfit.com
- Company type
- Private
- Founded year
- 1990
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Emfit Ltd is a Finland-based manufacturer founded in 1990 that builds contact-free, under-mattress ballistocardiography sensors for sleep tracking, HRV/recovery, seizure detection, and senior care monitoring, selling via subscription, enterprise sales, APIs, and regional distributors.
- Ownership category
- akta.pro rank
Emfit industry classification
Industry- Product category
- Contact-Free Vital Signs Sensors
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- ECG/EKG & Heart Rhythm Monitors (Consumer) (CRACAQAC)
Keywords
Where Emfit is headquartered
LocationHeadquarters
- HQ city
- Vaajakoski
- HQ country
- Finland
- HQ region
- Europe
Offices2 records
Markets served
Emfit business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales
Revenue model
- EMFIT QS Hardware + Subscription: Combined hardware device sale with ongoing subscription for data processing and cloud services. Starting March 2024, devices sold under subscription model. First year: 180 EUR/USD, second year: 100 EUR/USD, thereafter: 50 EUR/USD annual.
- EMFIT CARE Monthly Subscription: Monthly subscription model for senior care facilities: 15.85 EUR/month (WiFi version), 19.85 EUR/month (LTE-M cellular). Includes hardware startup fee of 198.75-238.75 EUR. Minimum order 3 units.
- EMFIT MM Distribution: Movement monitor for seizure detection sold through distribution partners (Epi USA for North America, Abilia elsewhere). Revenue through distribution partner sales.
- Research API & Licensing: API access and software licensing for research institutions and system integrators. SleepPeriod API and Band-Pass-filtered BCG Signal API offered for autonomous clinical data collection.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | EMFIT QS - Year 1 subscription |
| Subscription | Annual | EMFIT QS - Year 2 subscription |
| Subscription | Annual | EMFIT QS - Year 3+ subscription |
| Subscription | Monthly | EMFIT CARE WiFi - Monthly |
| Subscription | Monthly | EMFIT CARE LTE-M - Monthly |
| Other | Pay-as-you-go | EMFIT CARE Hardware Startup Fee |
| Subscription | Multi-year contract | EMFIT QS for Research/OEM |
Go-to-market motion4 records
Distribution channels5 records
Marketing channels6 records
Emfit product offering
Product offeringCore offering
Emfit is a manufacturer of non-contact vital signs and movement sensors built on proprietary ferro-electret ballistocardiography technology. The company sells under-mattress sensors and accompanying cloud data services across consumer wellness (EMFIT QS sleep and recovery monitor), senior care (EMFIT CARE bed and chair occupancy sensor), epilepsy (EMFIT MM seizure movement monitor), and research/OEM integrations (EMFIT QS Cloud API).
Product overview
Emfit offers a portfolio of contact-free health monitoring products based on proprietary ballistocardiography and ferro-electret sensor technology. The core product line includes EMFIT QS® for personal sleep and recovery tracking, EMFIT MM™ for seizure detection, and EMFIT CARE™ for professional senior care applications. All products utilize under-mattress sensors that require no wearable devices, with data processed through cloud-based analytics. The portfolio spans personal wellness (athletes, health-conscious individuals), clinical care (elderly fall prevention, epilepsy monitoring), and research applications (universities, pharmaceutical companies). Products are available as hardware with subscription-based data services, with API access for system integrators and OEM partners.
Differentiator
Problem solved
Functional benefit
Brands
- EMFIT QS: Contact-free sleep and recovery monitor for personal use, tracking heart rate variability (HRV), sleep stages, and autonomic nervous system balance.
- EMFIT MM
- EMFIT CARE
Products and services
- EMFIT QS
- EMFIT MM
- EMFIT CARE
- EMFIT QS Cloud API
Quantifiable outcome
- Night-time nursing patrol reduced by up to 90%
- +3 more outcomes
Companies that use Emfit
Customer profileNamed customers6 records
Segments7 records
Ideal customer profiles4 records
Emfit technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature6 records
Emfit partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- Epi USAcoreEpi USA is the exclusive distributor of EMFIT MM seizure movement monitor in USA, Canada, and Mexico. North American customers are redirected to www.epiusa.net for purchase. Emfit Ltd and Emfit Corp. are not affiliated with Epi USA.
- AbiliacoreAbilia distributes EMFIT MM seizure monitor outside North America (sold under Abilia brand). Represents core distribution partnership for international markets.
- Leading Hospitals, Pharmaceutical Companies, and UniversitiesminorEmfit collaborates with leading hospitals, pharmaceutical companies, and universities in Europe and USA. These partnerships helped create data APIs for demanding clinical research needs. Specific partners are not named publicly.
- World-Famous Universities and Research OrganizationsminorEmfit works with world-famous research organizations focusing on ballistocardiography and vibration/force sensing including acoustics and ultrasound. Specific organizations are not named publicly.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
Emfit competitors and assessment
Company assessmentBroad incumbents
- Apple (Apple Watch): Apple Watch provides ECG, HRV, and sleep tracking to a massive mainstream consumer base. As a broad incumbent in personal health monitoring, it is a key indirect competitor to EMFIT QS even though it uses a wearable form factor.
- Fitbit (Google): Fitbit, now part of Google, provides consumer sleep, HRV, and heart rhythm tracking across smartwatches and trackers. It is a broad incumbent in personal health monitoring overlapping EMFIT QS's positioning.
- ResMed: ResMed is a global leader in sleep and respiratory care, including sleep-disordered-breathing diagnostics. It is a broad incumbent in the sleep monitoring and care space where Emfit's QS and CARE products compete.
- Garmin: Garmin offers a wide range of smartwatches and fitness devices with advanced sleep, HRV, and recovery metrics. It is a broad incumbent in the sports and health-conscious segments that Emfit also serves with EMFIT QS.
Direct peers
- Withings: Withings sells a portfolio of connected health devices including sleep-tracking mats (Withings Sleep Analyzer) and ECG-capable watches. It is a direct peer to Emfit in consumer non-wearable/contact-free sleep and heart rhythm monitoring.
- EarlySense: EarlySense makes contact-free under-mattress sensors (InSight) for continuous vital signs monitoring in hospitals, senior care, and home settings, directly comparable to EMFIT CARE's bed-occupancy and vital signs monitoring use cases.
- Whoop: Whoop is a subscription-only wrist wearable focused on HRV, recovery, and sleep, used by professional athletes. It competes head-to-head with EMFIT QS in the athletic HRV/recovery segment with a similar subscription model.
- Oura: Oura Ring provides overnight HRV, sleep staging, and recovery scoring on a subscription basis. It targets the same athletes and health-conscious consumers as EMFIT QS, competing on the same HRV-during-sleep use case via a wearable form factor.
Emerging players
- Sleepace: Sleepace makes non-contact sleep monitoring sensors and bedside devices, including under-mattress strips. It is an emerging player with meaningful product overlap with EMFIT QS in the contact-free sleep tracking category.
- Tunstall Healthcare: Tunstall provides telecare and telehealth solutions, including bed occupancy sensors and fall-prevention technology for senior care. It overlaps with EMFIT CARE in the elderly care monitoring segment, particularly in the UK and Europe.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Emfit social profiles
Digital presenceEmfit compliance and trust
Trust signalCompliance5 records
Emfit financial estimates
Financial estimateRevenue estimate
Valuation estimate
Emfit leadership team
Management profileNumber of profiles
Profiles1 record
Emfit subsidiaries and ownership
Company hierarchySubsidiaries1 record
Emfit funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Emfit M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Emfit
What does Emfit do?
Emfit is a manufacturer of non-contact vital signs and movement sensors built on proprietary ferro-electret ballistocardiography technology. The company sells under-mattress sensors and accompanying cloud data services across consumer wellness (EMFIT QS sleep and recovery monitor), senior care (EMFIT CARE bed and chair occupancy sensor), epilepsy (EMFIT MM seizure movement monitor), and research/OEM integrations (EMFIT QS Cloud API).
Is Emfit a public or private company?
Emfit is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Emfit founded?
Emfit was founded in 1990. It employs 11 to 50 people.
Where is Emfit based?
Emfit is headquartered in Vaajakoski, Finland, in the Europe region.
How does Emfit make money?
Four revenue lines are on record. EMFIT QS Hardware + Subscription is the primary driver. The others are EMFIT CARE Monthly Subscription, EMFIT MM Distribution and research API & Licensing.
Who are Emfit's main competitors?
Broad incumbents on record are Apple (Apple Watch), Fitbit (Google), ResMed and Garmin. Direct peers are Withings, EarlySense, Whoop and Oura. Emerging players are Sleepace and Tunstall Healthcare.
Does Emfit have an API?
Yes. Emfit offers a cloud-based API for research and OEM use. The SleepPeriod API is a 'push API' that pushes all sleep period data to a given endpoint URL after a period has ended, providing heart rate, breathing rate, and movement activity data every 4 seconds, sleep staging every 30 seconds, and HRV RMSSD every 3 minutes. The Band-Pass-filtered BCG Signal API provides band-pass-filtered ballistocardiography sensor signal as a 'get API', with low band (0.07-3 Hz) sampled at 25 Hz and high band (1-50 Hz) sampled at 100 Hz. APIs are available for system integrators and OEMs, with options for full software licensing. Developer documentation is at emfit.com/sleep-research/emfit-qs-cloud-api.
What industry is Emfit in?
Emfit's product category is Contact-Free Vital Signs Sensors. Its primary akta.pro industry code is CRACAQAC, ECG/EKG & Heart Rhythm Monitors (Consumer). Its NAICS code is 334510 and its SIC code is 3845.